ArticleFrontiers in microbiology2023

The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein.

Sara Piacentini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.